SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 124 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $180,121 | -32.7% | 46,543 | +3.7% | 0.00% | -50.0% |
Q2 2023 | $267,532 | +90.4% | 44,888 | +4.5% | 0.00% | +100.0% |
Q1 2023 | $140,479 | -15.5% | 42,960 | +2.0% | 0.00% | 0.0% |
Q4 2022 | $166,315 | -34.5% | 42,105 | -0.4% | 0.00% | -50.0% |
Q3 2022 | $254,000 | -5.2% | 42,258 | +1.4% | 0.00% | 0.0% |
Q2 2022 | $268,000 | -24.3% | 41,661 | -2.8% | 0.00% | 0.0% |
Q1 2022 | $354,000 | -50.1% | 42,866 | -6.6% | 0.00% | -50.0% |
Q4 2021 | $710,000 | -33.3% | 45,883 | -2.9% | 0.00% | -33.3% |
Q3 2021 | $1,064,000 | +259.5% | 47,256 | +214.1% | 0.01% | +500.0% |
Q2 2021 | $296,000 | +1641.2% | 15,044 | +2798.7% | 0.00% | – |
Q1 2021 | $17,000 | – | 519 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 34,239,018 | $673,139,000 | 8.60% |
Trustees of Columbia University in the City of New York | 281,250 | $5,530,000 | 8.17% |
Crestline Management, LP | 3,210,937 | $63,127,000 | 5.44% |
Omega Fund Management, LLC | 843,750 | $16,588,000 | 1.88% |
Alphabet Inc. | 2,812,500 | $55,294,000 | 1.13% |
SB Management Ltd | 2,625,153 | $51,611,000 | 0.61% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,508,111 | $88,629,000 | 0.53% |
HARVARD MANAGEMENT CO INC | 468,749 | $9,216,000 | 0.53% |
Avidity Partners Management LP | 778,597 | $15,307,000 | 0.41% |
Dragoneer Investment Group | 1,500,000 | $29,490,000 | 0.38% |